M&A
Subrata Roy’s Plaza Hotel to be auctioned for mortgage defaults
By By Ravi Kunder | 17 Mar 2016
The five-star hotel off Central Park is majority owned by Subrata Roy’s Sahara India Pariwar, which defaulted on the mortgage payments By Ravi Kunder
China's Zoomlion sweetens bid for US crane maker Terex Corp to $3.4 bn
16 Mar 2016
Zoomlion believes the deal offers strategic benefits to both companies since Terex's main products are aerial work platforms, cranes and material handling equipment
Sony to buy Michael Jackson’s stake in Sony ATV JV for $750 mn
15 Mar 2016
ATV was founded in 1955 and acquired by Michael Jackson in 1985 for $41.5 million. In 1995, Michael Jackson merged his share with Sony's music-publishing catalogue to form Sony ATV
Campari close to buying global distribution business of French cognac maker Grand Marnier Group
15 Mar 2016
China's Anbang launches hostile $12.84-bn bid for Starwood Hotels
14 Mar 2016
A consortium led by China's Anbang Insurance Group has launched an unsolicited $12.84-billion bid to acquire Starwood Hotels and Resorts, potentially derailing the already planned takeover of the US hotel operator by Marriott International
Waldorf's Chinese owner Anbang to buy Strategic Hotels for $6.5 bn
14 Mar 2016
The Beijing-based insurer has recently made a push into buying overseas assets and made some high profile acquisitions
GM to buy autonomous vehicle technology software start-up Cruise Automation
12 Mar 2016
GM recently started dabbling in self-driving vehicle technology, and invested $500 million in Lyft, Inc an automated on-demand rides company, which led to starting its own car-sharing service company called Maven
European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions
11 Mar 2016
The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland
European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions
11 Mar 2016
The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland
European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions
11 Mar 2016
The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
